Correlation Between Apellis Pharmaceuticals and Mereo BioPharma
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Mereo BioPharma Group, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Mereo BioPharma.
Diversification Opportunities for Apellis Pharmaceuticals and Mereo BioPharma
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Apellis and Mereo is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Mereo BioPharma go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Mereo BioPharma
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to under-perform the Mereo BioPharma. In addition to that, Apellis Pharmaceuticals is 1.15 times more volatile than Mereo BioPharma Group. It trades about -0.03 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.08 per unit of volatility. If you would invest 135.00 in Mereo BioPharma Group on August 31, 2024 and sell it today you would earn a total of 226.00 from holding Mereo BioPharma Group or generate 167.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Mereo BioPharma Group
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Mereo BioPharma Group |
Apellis Pharmaceuticals and Mereo BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Mereo BioPharma
The main advantage of trading using opposite Apellis Pharmaceuticals and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Molecular Partners AG |
| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |